|
Vitamin E in the genesis and prevention of cancer. A review
|
15 December 2017 |
|
1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues
|
13 December 2017 |
|
Treatment of advanced pancreatic cancer with high-dose octreotide
|
29 November 2017 |
|
A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate
|
16 November 2017 |
|
Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines
|
10 November 2017 |
|
Prolactin and prolactin receptors are expressed and functioning in human prostate
|
10 November 2017 |
|
Combinational effects of vitamin D3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines
|
09 November 2017 |
|
Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas
|
27 October 2017 |
|
Feasibility, endocrine and anti-tumour effects of a triple endocrine therapy with tamoxifen, a somatostatin analogue and an antiprolactin in post-menopausal metastatic breast cancer: a randomized study with long-term follow-up
|
13 October 2017 |
|
The effects of the somatostatin analog octreotide on angiogenesis in vitro
|
13 October 2017 |